Abramov, S. et al. Landscape of allele-specific transcription factor binding in the human genome. Nat. Commun. 12, 2751 (2021).
- Alasoo, K. et al. Shared genetic effects on chromatin and gene expression indicate a role for enhancer priming in immune response. Nat. Genet. 50, 424–431 (2018).
Paper not yet in RePEc: Add citation now
Anzalone, A. V. et al. Search-and-replace genome editing without doublestrand breaks or donor DNA. Nature 576, 149–157 (2019). NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-022-29514-y ARTICLE NATURE COMMUNICATIONS | (2022)13:1855 | https://doi.org/10.1038/s41467-022-29514-y | www.nature.com/naturecommunications 55. Harley, J. B. et al. Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat. Genet. 50, 699–707 (2018).
- Baccala, R. et al. Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus. Proc. Natl Acad. Sci. USA 110, 2940–2945 (2013).
Paper not yet in RePEc: Add citation now
- Bashinskaya, V. V. et al. GWAS-identified multiple sclerosis risk loci involved in immune response: validation in Russians. J. Neuroimmunol. 282, 85–91 (2015).
Paper not yet in RePEc: Add citation now
- Beecham, A. H. et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45, 1353–1360 (2013).
Paper not yet in RePEc: Add citation now
Bell, C. C. et al. Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia. Nat. Commun. 10, 2723 (2019).
- Bentham, J. et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47, 1457–1464 (2015).
Paper not yet in RePEc: Add citation now
- Böhmdorfer, G. & Wierzbicki, A. T. Control of chromatin structure by long noncoding RNA. Trends Cell Biol. 25, 623–632 (2015).
Paper not yet in RePEc: Add citation now
- Bulger, M. & Groudine, M. Functional and mechanistic diversity of distal transcription enhancers. Cell 144, 327–339 (2011).
Paper not yet in RePEc: Add citation now
- Bushweller, J. H. Targeting transcription factors in cancer—from undruggable to reality. Nat. Rev. Cancer 19, 611–624 (2019).
Paper not yet in RePEc: Add citation now
- Chatterjee, S. et al. Enhancer variants synergistically drive dysfunction of a gene regulatory network in hirschsprung disease. Cell 167, 355–368.e10 (2016).
Paper not yet in RePEc: Add citation now
- Chen, A. & Koehler, A. N. Transcription factor inhibition: lessons learned and emerging targets. Trends Mol. Med. 26, 508–518 (2020).
Paper not yet in RePEc: Add citation now
- Choi, J. et al. Evidence for additive and synergistic action of mammalian enhancers during cell fate determination. Elife 10, e65381 (2021).
Paper not yet in RePEc: Add citation now
- Chrabot, B. S. et al. Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis. Genes Immun. 14, 471–478 (2013).
Paper not yet in RePEc: Add citation now
- Chu, C., Quinn, J. & Chang, H. Y. Chromatin isolation by RNA purification (ChIRP). J. Vis. Exp. 61, 3912 (2012).
Paper not yet in RePEc: Add citation now
- Consortium, G. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318–1330 (2020).
Paper not yet in RePEc: Add citation now
Cunninghame Graham, D. S. et al. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet. 7, e1002341 (2011).
- De Jager, P. L. et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 41, 776–782 (2009).
Paper not yet in RePEc: Add citation now
- Eyre, S. et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat. Genet. 44, 1336–1340 (2012).
Paper not yet in RePEc: Add citation now
- Farh, K. K.-H. et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337–343 (2015).
Paper not yet in RePEc: Add citation now
- Frangoul, H. et al. CRISPR-Cas9 gene editing for sickle cell disease and βthalassemia. N. Engl. J. Med. 384, 252–260 (2021).
Paper not yet in RePEc: Add citation now
- Fulco, C. P. et al. Activity-by-contact model of enhancer–promoter regulation from thousands of CRISPR perturbations. Nat. Genet. 51, 1664–1669 (2019).
Paper not yet in RePEc: Add citation now
- Fulco, C. P. et al. Systematic mapping of functional enhancer-promoter connections with CRISPR interference. Science 354, 769–773 (2016).
Paper not yet in RePEc: Add citation now
- Gasperini, M. et al. A genome-wide framework for mapping gene regulation via cellular genetic screens. Cell 176, 377–390.e19 (2019).
Paper not yet in RePEc: Add citation now
Gorlova, O. et al. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet. 7, e1002178 (2011).
- Gupta, R. M. et al. A genetic variant associated with five vascular diseases is a distal regulator of endothelin-1 gene expression. Cell 170, 522–533.e15 (2017).
Paper not yet in RePEc: Add citation now
- Ha, E., Bae, S. C. & Kim, K. Large-scale meta-analysis across East Asian and European populations updated genetic architecture and variant-driven biology of rheumatoid arthritis, identifying 11 novel susceptibility loci. Ann. Rheum. Dis. 80, 558–565 (2020).
Paper not yet in RePEc: Add citation now
- Hagberg, N. et al. The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE. Ann. Rheum. Dis. 77, 1070–1077 (2018).
Paper not yet in RePEc: Add citation now
- Hong, S. et al. Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy. J. Exp. Med. 216, 1154–1169 (2019).
Paper not yet in RePEc: Add citation now
- Hou, G. et al. SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression. Nat. Commun. 12, 135 (2021).
Paper not yet in RePEc: Add citation now
- Hu, Y. et al. Development of a molecular signature to monitor pharmacodynamic responses mediated by in vivo administration of glucocorticoids. Arthritis Rheumatol. 70, 1331–1342 (2018).
Paper not yet in RePEc: Add citation now
- Hughes, J. R. et al. Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment. Nat. Genet 46, 205–212 (2014).
Paper not yet in RePEc: Add citation now
- Jin, F., Li, Y., Ren, B. & Natarajan, R. PU.1 and C/EBPα synergistically program distinct response to NF-κB activation through establishing monocyte specific enhancers. Proc. Natl Acad. Sci. USA 108, 5290–5295 (2011).
Paper not yet in RePEc: Add citation now
- Karagianni, P. & Tzioufas, A. G. Epigenetic perspectives on systemic autoimmune disease. J. Autoimmun. 104, 102315 (2019).
Paper not yet in RePEc: Add citation now
Konermann, S. et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517, 583–588 (2015).
- Kuriakose, J. et al. Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis. J. Clin. Invest. 129, 2251–2265 (2019).
Paper not yet in RePEc: Add citation now
- Lambert, S. A. et al. The human transcription factors. Cell 172, 650–665 (2018).
Paper not yet in RePEc: Add citation now
- Lessard, Christopher, J. et al. Identification of IRF8, TMEM39A, and IKZF3ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am. J. Hum. Genet. 90, 648–660 (2012).
Paper not yet in RePEc: Add citation now
- Li, S. W., He, Y., Zheng, Z. H., Liu, D. W. & Liu, Z. S. Single-nucleotide polymorphisms of IRF8 gene are associated with systemic lupus erythematosus in Chinese Han population. Int J. Immunogenet. 41, 112–118 (2014).
Paper not yet in RePEc: Add citation now
- Liu, N. et al. Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch. Cell 173, 430–442.e17 (2018).
Paper not yet in RePEc: Add citation now
- Liu, T. et al. Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol. 12, R83 (2011).
Paper not yet in RePEc: Add citation now
- López-Isac, E. et al. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways. Nat. Commun. 10, 4955 (2019).
Paper not yet in RePEc: Add citation now
Lu, X. et al. Global discovery of lupus genetic risk variant allelic enhancer activity. Nat. Commun. 12, 1611 (2021).
- Marquis, J. F. et al. Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis. PLoS Genet. 7, e1002097 (2011).
Paper not yet in RePEc: Add citation now
- Matana, A. et al. Genome-wide analysis identifies two susceptibility loci for positive thyroid peroxidase and thyroglobulin antibodies. J. Clin. Endocrinol. Metab. 105, dgz239 (2020).
Paper not yet in RePEc: Add citation now
- Miguel-Escalada, I. et al. Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes. Nat. Genet. 51, 1137–1148 (2019).
Paper not yet in RePEc: Add citation now
- Mohaghegh, N. et al. NextPBM: a platform to study cell-specific transcription factor binding and cooperativity. Nucleic Acids Res. 47, e31 (2019).
Paper not yet in RePEc: Add citation now
- Mohammadi, P., Castel, S. E., Brown, A. A. & Lappalainen, T. Quantifying the regulatory effect size of cis-acting genetic variation using allelic fold change. Genome Res. 27, 1872–1884 (2017).
Paper not yet in RePEc: Add citation now
- Muppirala, U. K., Honavar, V. G. & Dobbs, D. Predicting RNA-protein interactions using only sequence information. BMC Bioinforma. 12, 489 (2011).
Paper not yet in RePEc: Add citation now
- Muppirala, U. K., Lewis, B. A. & Dobbs, D. Computational tools for investigating RNA-protein interaction partners. J. Comput. Sci. Syst. Biol. 6, 182–187 (2013).
Paper not yet in RePEc: Add citation now
- Murakami, K. et al. A RUNX-CBFβ-driven enhancer directs the Irf8 dosedependent lineage choice between DCs and monocytes. Nat. Immunol. 22, 301–311 (2021).
Paper not yet in RePEc: Add citation now
Nasser, J. et al. Genome-wide enhancer maps link risk variants to disease genes. Nature 593, 238–243 (2021).
- O’Shea, J. J. & Plenge, R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 36, 542–550 (2012).
Paper not yet in RePEc: Add citation now
- Oleksiak, M. F., Churchill, G. A. & Crawford, D. L. Variation in gene expression within and among natural populations. Nat. Genet. 32, 261–266 (2002).
Paper not yet in RePEc: Add citation now
- Ota, M. et al. Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases. Cell 184, 3006–3021.e17 (2021).
Paper not yet in RePEc: Add citation now
- Panwar, B. et al. Multi-cell type gene coexpression network analysis reveals coordinated interferon response and cross-cell type correlations in systemic lupus erythematosus. Genome Res. 31, 659–676 (2021).
Paper not yet in RePEc: Add citation now
- Parry, A., Rulands, S. & Reik, W. Active turnover of DNA methylation during cell fate decisions. Nat. Rev. Genet. 22, 59–66 (2021).
Paper not yet in RePEc: Add citation now
- Pathak, S., Ma, S., Shukla, V. & Lu, R. A role for IRF8 in B cell anergy. J. Immunol. 191, 6222–6230 (2013).
Paper not yet in RePEc: Add citation now
- Peng, S. L. Transcription factors in autoimmune diseases. Front. Biosci. 13, 4218–4240 (2008).
Paper not yet in RePEc: Add citation now
- Petri, M. et al. Association between changes in gene signatures expression and disease activity among patients with systemic lupus erythematosus. BMC Med Genomics 12, 4 (2019).
Paper not yet in RePEc: Add citation now
- Salem, S. et al. Functional characterization of the human dendritic cell immunodeficiency associated with the IRF8(K108E) mutation. Blood 124, 1894–1904 (2014).
Paper not yet in RePEc: Add citation now
- Salem, S., Salem, D. & Gros, P. Role of IRF8 in immune cells functions, protection against infections, and susceptibility to inflammatory diseases. Hum. Genet 139, 707–721 (2020).
Paper not yet in RePEc: Add citation now
- Sankaran, V. G. et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 322, 1839–1842 (2008).
Paper not yet in RePEc: Add citation now
- Savitsky, D. A., Yanai, H., Tamura, T., Taniguchi, T. & Honda, K. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proc. Natl Acad. Sci. USA 107, 10154–10159 (2010).
Paper not yet in RePEc: Add citation now
- Schmiedel, B. J. et al. Impact of genetic polymorphisms on human immune. Cell Gene Expr. Cell 175, 1701–1715.e16 (2018).
Paper not yet in RePEc: Add citation now
- Sheng, Y. J. et al. Association analyses confirm five susceptibility loci for systemic lupus erythematosus in the Han Chinese population. Arthritis Res Ther. 17, 85 (2015).
Paper not yet in RePEc: Add citation now
- Shin, H. Y. Targeting super-enhancers for disease treatment and diagnosis. Mol. Cells 41, 506–514 (2018).
Paper not yet in RePEc: Add citation now
Simeonov, D. R. et al. Discovery of stimulation-responsive immune enhancers with CRISPR activation. Nature 549, 111–115 (2017).
- Sjöstrand, M. et al. Expression of the immune regulator tripartite-motif 21 is controlled by IFN regulatory factors. J. Immunol. 191, 3753–3763 (2013).
Paper not yet in RePEc: Add citation now
- Song, S. et al. Inhibition of IRF5 hyperactivation protects from lupus onset and severity. J. Clin. Invest 130, 6700–6717 (2020).
Paper not yet in RePEc: Add citation now
- Statello, L., Guo, C. J., Chen, L. L. & Huarte, M. Gene regulation by long noncoding RNAs and its biological functions. Nat. Rev. Mol. Cell Biol. 22, 96–118 (2021).
Paper not yet in RePEc: Add citation now
- Sun, S. C. The non-canonical NF-κB pathway in immunity and inflammation. Nat. Rev. Immunol. 17, 545–558 (2017).
Paper not yet in RePEc: Add citation now
- Takeuchi, M. et al. Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behçet’s disease susceptibility. Nat. Genet 49, 438–443 (2017).
Paper not yet in RePEc: Add citation now
- Thakore, P. I. et al. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nat. Methods 12, 1143–1149 (2015).
Paper not yet in RePEc: Add citation now
- Tsai, M. C. et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 329, 689–693 (2010).
Paper not yet in RePEc: Add citation now
- van der Wijst, M. G. P. et al. Single-cell RNA sequencing identifies celltypespecific cis-eQTLs and co-expression QTLs. Nat. Genet. 50, 493–497 (2018).
Paper not yet in RePEc: Add citation now
Wang, Y. F. et al. Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups. Nat. Commun. 12, 772 (2021).
- White, C. L., Kessler, P. M., Dickerman, B. K., Ozato, K. & Sen, G. C. Interferon regulatory factor 8 (IRF8) impairs induction of interferon induced with tetratricopeptide repeat motif (IFIT) gene family members. J. Biol. Chem. 291, 13535–13545 (2016).
Paper not yet in RePEc: Add citation now
- Yin, X. et al. Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus. Ann. Rheum. Dis. 80, 632–640 (2020).
Paper not yet in RePEc: Add citation now
- Yu, B. et al. B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells. Cell 184, 1790–1803.e17 (2021).
Paper not yet in RePEc: Add citation now